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A B S T R A C T 
The authors shared their results from the validation in a guinea pig model of a new ossicular prosthesis with 
Targis/Vectris System (Ivoclar, Lichtenstein). During the previous two years, the biocompatibility of teflon, 
gold, and ceramics was assessed. The biocompatibility of Targis and Vectris materials does not exist anymore 
as they are used in dental practice since 9 years. Targis is a ceramic optimized polymer of the family of 
ceromers. Vectris is a high-technology material replacing the metal substructure. These materials were in-
serted into a new medium, in the middle ear of a guinea pig. The experiments were carried out for different pe-
riods of time - 29 days, 70 days and 260 days. The ossicular prostheses were histologically examined. Targis 
and Vectris implanted retroauricularily into guinea pig' middle ear cavity did not show any inflamma-
tory-reaction signs when contacting the skin of the external auditory channel. They proved to be well biologi-
cally tolerated even after 260 days after implantation. 
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I N T R O D U C T I O N 
The sounds from the ear canal can be transmitted to the in-
ner ear in two ways: by the tympano-ossicular system 
(ossicular coupling) and by the direct acoustic stimulation 
of the oval and round windows (acoustic coupling) (17). 
When the ossicular chain is definitely damaged, it may be 
reconstructed using grafts or prostheses of different kind 
(6,7,19). 
The idea of ossicular chain reconstruction (OCR) emerges 
and develops consequently from the creation of Wulstein's 
(22) and Zollner's (23) concept of tympanoplasty. Shea 
(21) moved from the concept of a graft to that of a 
bioprosthesis. He first began a successful series of OCR. 
Through the subsequent contributions of several authors 
(2,3,9,10,11,13) in the early 60s, a major pathway in the 
field of OCR was opened. In the next years, the advances in 
the new biomaterials permit the fabrication of commercial-
ized ossicular prostheses of different kind, many of which 
remain still topical. The biomaterials used for OCR should 
possess a good biocompatibility and biostability (12). They 
must be well osteointegrated, with minimal risk of 
ankylosis (14). Their surface properties, and particularly 
their structural characteristics, critically influence the qual-
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ity of the implant-recipient interface. Besides they should 
be easily processed and of stable shape. A proper sound 
transmission requires biomaterials of low mass and high 
hardness (16). In modern otosurgery, a large variety of 
biomaterials were made use of (1,4,5,6,7,8,15,20). None of 
them is, however, useful for any applications. 
The aim of the present communication is to share the results 
from the validation in a guinea pig model of a new ossicular 
prosthesis with Targis/Vectris System dental polymer ma-
terials first used for ossiculoplasty. This system combines 
the advantages of the ceramics and plastics in one. 
M A T E R I A L AND M E T H O D S 
1. Animal selection and initial surgery 
Fourteen adult guinea pigs of either sex, weighing between 
350 and 500g, were selected and housed according to the 
Guide for the Care and Use of Laboratory Animals. Prior to 
surgery, the animals received an i. m. premedication bolus 
of 0,05mg/kg of atropine sulfate. Fifteen min later they 
were anesthesized using Xylazin 2% i. m. After 5min 
Ketamin i. m. was injected in a dose of 5mg/kg. The 
retroauricular areas were shaved and disinfected with 
Braunol. The implant was inserted in two sites using 
biomicroscope: in the middle ear cavity through the exter-
nal auditory canal and in the bulla mastoidea using a mas-
toid trepanation. Each animal received antibiotics (Penicil-
lin) during the operation. Two animals died during the ini-
tial surgery. The animals were returned to their cages and 
fed an unrestricted standard diet until the sacrifice. Each an-
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imal received antibiotics three days after the operation 
(Penicillin). 
2. Second surgery 
Four animals underwent re-operation after four weeks. In 
each case, the second implant was inserted subdennally in 
the retroauricular area 
3. Harvesting and processing 
Twelve animals were sacrificed either with an overdose of 
)entobarbital, or by exsanguination on day 29, 70 and 260 
tfter initial surgery (Table 1). 
"able 1. Distribution of animal ears according to the 









9 day 4 4 1 
Oday 2 2 1 
50 day 6 6 4 
otal 12 12 6 
е implanted prosthesis was excised with some surround-
! tissues and fixed in a 10% formalin solution. Macro-
ipic pictures were taken from certain specimens. 
Light microscopy 
Dresentative specimens of harvested materials were cut. 
: biomaterial was explanted from the surrounding tis-
s when possible. All these pieces were embedded in 
towax, 5-u.m sections were cut and stained with 
latoxylin-eosin, with AZAN, and by Masson's 
irome method. 
R E S U L T S AND D I S C U S S I O N 
Jssicular prostheses explanted on day 29 after 
mplantation 
nty-nine days after implantation the ossicular prosthe-
mplanted in the bulla mastoidea or cavum tympani 
ii to be covered by thin capsule in the process of 
'ization. In this capsule, two layers can be distin-
led - an internal layer which contacts the prosthesis it-
ind an external one which covers the internal layer, 
rea of the capsule lying between the osseous wall and 
osmesis is at a more advanced stage of cicatrization in 
arison with that localized between the prosthesis and 
astoid or tympanic cavity, respectively, 
eternal layer (towards the bone) of the area of the cap-
'ing between the osseous wall and the prosthesis con-
f collagen fibers and fibroblasts (Fig. 1). 
Fig. 1. Ossicular prosthesies explanted on day 29. The 
inner layer of a capsule disposed between the prosthesis 
and the mastoid/tympanic cavity, in which a small 
number of fibroblasts composing a fine grid are 
observed. Hematoxylin-eosin. Magn. x200. 
Young cells with ovoid nuclei can be seen inwards and 
loosely linked with the connective fibres in which single in­
flammatory cells are ascertained in some animals. 
The external layer has no sharp bordeline to the inner layer 
composed of small number of inflammatory cells in degen­
eration (necrotic polymorphonuclear cells along with 
groups of necrotic macrophages). The cells present with 
condensed chromatin and picnotic nuclei that suggests a 
possible apoptosis. 
Fig. 2. Ossicular prosthesis explanted on day 29. In the 
inner layer of a capsule disposed between the prosthesis 
and the mastoid/tympanic cavity blood vessels with thin 
walls can be seen (neoangiogenesis). Hematoxylin-
eosin. Magn. x 200 
The external layer of a part of the capsule disposed between 
the prosthesis and the mastoid/tympanic cavity consists 
mainly of a numerous collagen fibers infiltrated with re­
duced number of inflammatory cells. In this layer, lympho­
cytes are most frequently observed but less monocytes and 
macrophages. However, in some animals a small quantity 
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of eosinophils and neutrophils can be seen. Heaps of dead 
and degenerated cells may be observed. In some regions 
there is a cicatrization in advanced stage. There are a few of 
inflammatory cells while the fibroblasts are more abundant. 
This external fibroblast layer is formed and grows from the 
periost of the mastoid cavity. 
The inner layer of a capsule disposed between the prosthe-
sis and the mastoid/tympanic cavity bordering the implant 
is of irregular thickness. It is composed of plasma proteins 
in process of cicatrization. In this layer there are few 
fibroblasts composing a fine grid. 
The blood vessels with thin walls filled with erythrocytes 
can be seen, too (neoangiogenesis). The capsule is infil-
trated by inflammatory cells the main pail of which being a 
small group of macrophages. In some macrophages vacu-
oles (Fig. 2) in the cytoplasm and chromatin-like spokes 
can be seen. 
According to their frequency the lymphocytes are the sec-
ond cell population. Some of them are with picnotic nuclei. 
The polymorphonuclear cells (PMNC) or their residues are 
rarely observed and manifest symptoms suggesting 
apoptosis. Some cells of average size are disposed in the 
immediate vicinity of the material. Separate eosinophils 
with degenerative changes are found out, too (Fig. 3). In the 
lumen of the capsular neovessels eosinophils can be ob-
served, too. 
In some animals there are inflammatory cells such as 
PMNC, lymphocytes, monocytes and macrophages on the 
surface of the implant sections. Some cells manifest symp-
toms suggesting apoptosis. 
Fig. 3. Ossicular prosthesis explanted on day 29. Close 
contact between the implant and recipient capsule. The 
residues from PMNC with symptoms suggesting the 
apoptosis in the material are disposed. Hematoxylin-
eosin. Magn. x 200 
I I . Implants explanted on day 70 after implantation 
At the implantation of the prosthesis in the tympanic cavity 
for 70 days a fine connective tissue capsule was formed 
around the implant which consisted of 1 to 4 rows of 
fibroblasts (Fig 4). In one of the implanted animals separate 
or in-gioups of about 10 inflammatory cells in some small 
regions around the capsule were observed. These were 
mainly macrophages and monocytes. In the other animal no 
inflammatory cells were found at all. 
There was an impressively good contact between the con-
junctive tissue capsule and the implant. There are no cal-
cium deposits at all. Inside the pores of the implant some 
Fig. 4. Ossicular prosthesis explanted on day 260. 
Around the prostheses in cavum tympani, well-
developed connective tissue capsule. Hematoxylin-
eosin. Magn. x 200. 
cells with picnotic nuclei were observed, probably 
macrophages. Their appearance suggests the presence of 
apoptosis. 
I I I . Implants explanted on day 260 after implantation 
Around the prostheses implanted for 260 days in cavum 
tympani, well-developed connective tissue capsule was 
found. In two of the implanted animals, single regions of 
the capsule were infiltrated with macrophages or with 
macrophages and lymphocytes. The tissues of external au-
ditory meatus contacting the implant remain intact. 
Around the prosthesis implanted in the subcutaneous tissue 
behind the cartilaginous part of the ear orifice, there is a 
well-shaped conjunctive tissue capsule. It is composed of 
several (up to 10) fascicles of collagen fibers and fibroblasts 
between them. In the capsule there are well-developed 
blood vessels (neoangiogenesis). At certain areas 
monocytes, macrophages, lymphocytes, and eosinophils 
are observed. At some small areas, between the material 
and the capsule, there are remainders of non-organized 
fibrinous mass containing macrophages. On the edge of the 
material and the remainder of non-organized fibrin, in the 
capsule may be found single macrophages. The tissues 
around the capsule are without changes. Hyperemia in 
some areas can be seen only. Separate lymphocytes are ob-
served. 
The capsule from the side of the muscle has the same struc-
ture in principle. On the edge of the capsule and the trans-
versely furrowed musculature there are conjunctive tissue 
filaments penetrating between the fascicles of the muscle. 
The remaining parts of the muscle are without any changes. 
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The limited graft applications in the reconstructive audi-
tory-chain surgery stimulated the search for a new pros-
thetic medical device. There are certain advances in the de-
velopment of prosthesis fabrication designed for 
ossiculoplasty in recent years, indeed. Several questions are 
of paramount interest for solving this problem: 
1. Biomaterial selection for the ossicular prosthesis 
construction; 
2. Design of the ossicular prosthesis; 
3. Validation of the ossicular prosthesis, and 
4. Monitoring of the patients with implanted ossicular 
prostheses. 
In this paper, we report the preliminary results from the val-
idation in the guinea pig models a new Targis/Vectris 
ossicular prosthesis. 
Targis is a ceramic optimized polymer of the family of 
:eromers. It contains about 78-85% of inorganic fillers with 
exactly measured contents of ceramic particles in them. The 
nterparticle spaces are filled with an organic polymer ma-
rix that enhances the homogeneity of the three- dimen-
;ional structure. 
/ectris is a high-technology material replacing the metal 
ubstructure. The material consists of numerous file-like 
dates layered one on the other and positioned in a common 
xis and fonning a common fascicle. It combines the op-
portunity to maintain long-lasting loading on the account of 
s lower own weight in combination with long-lasting elas-
city and lower internal tensions, 
l the combined application of these two materials, Vectris 
; used for the fabrication of prosthesis substructure while 
argis is used for its coverage. In the literature available, us-
je of different animals for biomaterial validations has been 
ported. In a series of experiments on rats several 
omaterials for ossiculoplasty were implanted such as 
)ld, teflon, hydroxyapatite, ceromer, hydroxyapatite+ 
ain-steel and Silicon+stain-steel while in guinea pigs gold, 
flon, hydroxyapatite, and ceromer were used convincing 
: in the good qualities of the guinea pig to serve as a model 
r testing the ossicular prostheses (18). In this experimen-
investigation in guinea pigs model, some promising re-
Its have been obtained (18). 
fer 29 day-long stay in the mastoid/tympanic cavity, the 
esthetic explants are covered by a fine capsule undergo-
l cicatrization. It consists of two layers. The cicatrization 
)cess is more advanced in the external layer presenting 
th outlined bundles of collagen and fibroblasts. This pro-
;s is less developed in the internal layer located closely to 
implant. There are scant)' inflammatory cells most of 
ich characterized by degeneration. In both layers there 
newly formed blood vessels (neoangiogenesis). Based 
these features we could suppose that, similarly to any 
slants, this one analyzed in the present study causes, in 
onset, hyperemia and moderate inflammatory reaction 
idly replaced by a healing process resulting into the for-
:ion of a connective-tissue capsule around the implant, i. 
:icatrization. These data are crucial taking into consider-
n the general rule that the rapid capsule formation and 
helization of the implant substantially contribute to the 
prevention of microorganism seeding. In certain cases, 
macrophages, monocytes and lymphocytes could be estab-
lished penetrating mainly in the pores on the external parts 
of the implant. These cells display degeneration signs. 
It stresses that both Targis and Vectris implanted 
retroauricularily into the middle ear cavity of a guinea pig 
do not show any inflammatory-reaction signs when con-
tacting the skin of the external auditory channel. A contami-
nation of the material with bacterial cells occuired in two 
cases only. Having in mind the localization of the inflam-
mation we allow us to assume that this material possesses 
bactericidal properties. 
Around the prostheses implanted for 70 days in the mas-
toid/tympanal cavity a fine connective tissue capsule con-
sisting of 1 to 4 rows of collagen bundles and fibroblasts is 
developed. Occasionally, in the capsule single monocytes 
and macrophages are seen. There exists a good contact be-
tween the connective tissue capsule and the implant itself. 
No calcium deposits could be detected. Cells with picnotic 
nuclei were observed, probably macrophages, inside the 
pores of the implant. Their appearance suggests the pres-
ence of apoptosis. 
Around the prostheses implanted for 260 days the process 
of cicatrization of a capsule is well finalized. In single re-
gions of the capsule only, infiltration by a few macrophages 
or by macrophages and lymphocytes was observed. No al-
terations in the tissues of external auditory meatus were ob-
served. 
Used in a specific environment such as mastoid/tympanic 
cavity and subdemially, Targis and Vectris prove to be well 
biologically tolerated, too, even after 260 days after implan-
tation. Their biocompatibility presents with a well-formed 
capsule of collagen fibres, fibroblasts and newly formed 
blood vessels. In some animals, inflammatory cells like 
monocytes and macrophages can be seen. This reaction is, 
however, weakly expressed and far from the definition of 
alien-type reaction with histocytes, macrophages and giant 
cells obligatorily necessitating cancellation of the clinical 
application of the corresponding biomaterials. 
C O N C L U S I O N 
The insertion of the Targis and Vectris implants in two 
sites, under the skin behind the auricle where the prosthesis 
contacts the subdermal adipose tissue and muscles and in 
the middle ear cavity and bulla mastoidea through two ap-
proaches (through the external auditory canal or through the 
mastoid cavity) enables the successful investigation of 
Targis and Vectris OCR biocompatibility (18). 
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